Key Takeaway
Melanotan II's effects on libido and sexual function are among its most documented benefits. Learn about the melanocortin mechanism, clinical evidence, and what to expect.
Quick Answer: Melanotan II for libido is one of its most well-documented effects. By activating MC3R and MC4R in the central nervous system, it stimulates sexual arousal pathways independently of peripheral vascular mechanisms. Clinical trials demonstrated improved erectile function in men and increased sexual desire in both sexes. This effect led directly to the development of bremelanotide (Vyleesi), an FDA-approved sexual dysfunction medication derived from the same melanocortin platform.
How Melanotan II Enhances Libido
Unlike PDE5 inhibitors (Viagra, Cialis) that work by increasing blood flow to genital tissue, Melanotan II acts on the brain. It activates MC3R and MC4R receptors in the hypothalamus and limbic system, the regions that govern sexual desire and arousal.
This central mechanism means Melanotan II affects desire (wanting sex), not just the mechanical ability to perform. This is an important distinction because many people with low libido have adequate blood flow but lack the desire or mental arousal component.
In Men
The first clinical observation of Melanotan II's sexual effects came during early tanning trials when male subjects reported spontaneous erections 1 to 5 hours after injection. Subsequent studies in the International Journal of Impotence Research confirmed that Melanotan II improved erectile function in men with erectile dysfunction, including some who had not responded to PDE5 inhibitors.
In Women
Research showed that melanocortin agonists increased genital arousal and sexual desire in women. This finding ultimately led to the development of bremelanotide (Vyleesi), approved by the FDA in 2019 for hypoactive sexual desire disorder (HSDD) in premenopausal women.
Clinical Evidence Summary
| Study/Finding | Population | Result |
|---|---|---|
| Phase I tanning trials | Healthy males | Spontaneous erections observed as side effect |
| Wessells et al., IJIR | Men with ED | Improved erectile response vs placebo |
| Diamond et al., Urology | Men with ED | 73% reported improved erections (vs 27% placebo) |
| Bremelanotide trials (related) | Women with HSDD | Significant improvement in desire and arousal |
What to Expect
- Onset: Sexual effects typically begin 1 to 5 hours after injection
- Duration: Effects can last 6 to 72 hours after a single dose, varying by individual
- Both desire and function: Users report increased interest in sex (desire) as well as improved physical response (arousal, erection quality)
- Dose-dependent: Higher doses produce more pronounced effects but also more side effects (nausea, flushing)
- Tolerance: Some users report diminishing sexual effects over extended continuous use, supporting the importance of cycling
Melanotan II vs Bremelanotide (Vyleesi)
| Factor | Melanotan II | Bremelanotide (Vyleesi) |
|---|---|---|
| FDA approved | No | Yes (HSDD in women) |
| Receptor selectivity | Non-selective (MC1R-MC5R) | MC4R preferring |
| Tanning effect | Yes | Minimal |
| Administration | Subcutaneous injection | Subcutaneous autoinjector |
| Dosing | Daily or per protocol | As needed (45 min before) |
| Nausea incidence | 50-80% | ~40% |
| Cost | Contact provider for current pricing | Contact provider for current pricing |
Important Considerations
- Priapism risk: In rare cases, prolonged erections lasting more than 4 hours have been reported. This is a medical emergency requiring immediate attention.
- Not a standalone ED treatment: While Melanotan II can improve erectile function, it isn't a substitute for a thorough evaluation of erectile dysfunction causes.
- Cardiovascular assessment: Sexual activity places cardiovascular demands. Patients with heart conditions should be evaluated before using any sexual enhancement compound.
- Psychological factors: Low libido often has psychological components (stress, relationship issues, depression) that peptides can't address alone.
Frequently Asked Questions
How quickly does Melanotan II affect libido?
Most users notice sexual effects within 1 to 5 hours of injection. Some report that the effect builds over several days of consistent use, with a cumulative enhancement in baseline desire.
Check your GLP-1 eligibility
Use our free BMI Calculator to see if you may qualify for provider-reviewed GLP-1 therapy.
Try the BMI Calculator →View data table
| Category | Clinical Interest Score | Detail |
|---|---|---|
| BPC-157 | 88 | Tissue repair and gut healing |
| TB-500 | 82 | Injury recovery |
| Sermorelin | 78 | Growth hormone support |
| Ipamorelin | 75 | Anti-aging and recovery |
| GHK-Cu | 70 | Skin and tissue repair |
Does Melanotan II work for women's libido?
Yes. The melanocortin pathway increases sexual desire through central brain mechanisms that operate in both sexes. The FDA approval of bremelanotide (derived from this research) specifically for women's sexual desire disorder validates this mechanism.
Can I use Melanotan II just for sexual benefits?
Some users do, but keep in mind that you'll also experience tanning, nausea, and other melanocortin effects. If sexual function is your sole concern, discuss bremelanotide or other targeted options with your physician.
Will the libido effect diminish over time?
Some users report tolerance with continuous daily use. Cycling (using for 4-6 weeks then taking a break) helps maintain the sexual response. See our Melanotan II cycling protocol guide.
Discuss Sexual Health with a Physician
Sexual health is health. At FormBlends, our physicians create confidential, judgment-free treatment plans that address your needs with evidence-based options.
Disclaimer: This article is for informational purposes only and doesn't constitute medical advice. Melanotan II isn't FDA-approved for any medical condition. Always consult with a licensed healthcare provider before beginning any peptide therapy. Individual results may vary.